Ava S. Harb
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ava S. Harb has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Anne Pelletier Cameron
Department of Urology, University of Michigan, Ann Arbor, USA
1 shared publication Beau Ahrens
Dalhousie University Halifax Nova Scotia Canada
1 shared publication- Caitlin Seibel
University of Michigan Department of Urology Ann Arbor MI USA
1 shared publication Catherine Anderson
Independent Researcher, Founder of International “Living With Idiopathic Subglottic Stenosis” Support Community Bristol UK
1 shared publicationFatemah Ramazani
Department of Otolaryngology Head and Neck Surgery University of Calgary Calgary Alberta Canada
1 shared publication- Giulia Ippolito Lane
University of Michigan Ann Arbor Michigan USA
1 shared publication
Latest Publications
- Open Access
- 22 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5) , e70607
Geographic Clustering of Idiopathic Subglottic Stenosis in North America: An Ecological Cohort Study
Background: Idiopathic subglottic stenosis (iSGS) is a recurrent fibroinflammatory narrowing of the subglottis, typically affecting White pre‐ and perimenopausal women. While its etiology remains uncertain, inflammatory signaling, reflux, hormonal influences, and mycobacterial factors have been proposed. This study evaluated geographic variability in survey‐ascertained iSGS prevalence, exploring potential environmental correlates associated with regional disease distribution. Methods: A retrospective ecological analysis of self‐reported demographic and clinical data from members of an international iSGS online support group was performed. Responses were analyzed by continent, country, and US state or Canadian province. Estimated prevalence per 1,000,000 White females was calculated using census data and examined in relation to environmental and access‐related factors, including temperature, humidity, and particulate matter. Results: Among 4450 survey respondents, 99.3% were female and 83.8% reported symptom onset after age 30. Survey‐ascertained prevalence was highest in Wyoming (18.1), Utah (17.4), Iowa (15.3), Colorado (13.9), and Minnesota (12.1), and lowest in New Hampshire (1.2), Montana (1.5), Alaska (2.3), and Indiana (2.3). In Canada, survey‐ascertained prevalence was highest in Alberta (85.4) and Saskatchewan (65.3), and lowest in Quebec (2.9). Higher prevalence regions were geographically clustered in areas sharing dry or semi‐arid climates, higher elevation, higher temperature and lower humidity. PM2.5 modified the association between elevation and survey‐ascertained prevalence but was not independently associated with prevalence. Conclusions: iSGS demonstrated geographic clustering in North America associated with higher altitude, lower humidity and higher temperatures; however, these ecological findings should be considered hypothesis‐generating and warrant further investigation using patient‐level exposure and biologic data. Level of Evidence: This study represents Level 4 evidence given its ecological, cross‐sectional design.
- 22 October 2026
- Published by Wiley in Laryngoscope Investigative Otolaryngology
- Vol. 11 (5) , e70607
Open AccessGeographic Clustering of Idiopathic Subglottic Stenosis in North America: An Ecological Cohort Study
Background: Idiopathic subglottic stenosis (iSGS) is a recurrent fibroinflammatory narrowing of the subglottis, typically affecting White pre‐ and perimenopausal women. While its etiology remains uncertain, inflammatory signaling, reflux, hormonal influences, and mycobacterial factors have been proposed. This study evaluated geographic variability in survey‐ascertained iSGS prevalence, exploring potential environmental correlates associated with regional disease distribution. Methods: A retrospective ecological analysis of self‐reported demographic and clinical data from members of an international iSGS online support group was performed. Responses were analyzed by continent, country, and US state or Canadian province. Estimated prevalence per 1,000,000 White females was calculated using census data and examined in relation to environmental and access‐related factors, including temperature, humidity, and particulate matter. Results: Among 4450 survey respondents, 99.3% were female and 83.8% reported symptom onset after age 30. Survey‐ascertained prevalence was highest in Wyoming (18.1), Utah (17.4), Iowa (15.3), Colorado (13.9), and Minnesota (12.1), and lowest in New Hampshire (1.2), Montana (1.5), Alaska (2.3), and Indiana (2.3). In Canada, survey‐ascertained prevalence was highest in Alberta (85.4) and Saskatchewan (65.3), and lowest in Quebec (2.9). Higher prevalence regions were geographically clustered in areas sharing dry or semi‐arid climates, higher elevation, higher temperature and lower humidity. PM2.5 modified the association between elevation and survey‐ascertained prevalence but was not independently associated with prevalence. Conclusions: iSGS demonstrated geographic clustering in North America associated with higher altitude, lower humidity and higher temperatures; however, these ecological findings should be considered hypothesis‐generating and warrant further investigation using patient‐level exposure and biologic data. Level of Evidence: This study represents Level 4 evidence given its ecological, cross‐sectional design.
- 10 August 2026
- Published by Wiley in Neurourology and Urodynamics
Retrospective Evaluation of Contemporary Complication Rates and Severity After Suprapubic Tube Placement by Urology and Interventional Radiology
Introduction: To compare complication rates and severity associated with suprapubic tube (SPT) placement by urology versus interventional radiology (IR) and to identify patient factors associated with increased complication risk. Methods: A retrospective, single‐center review from 2017 to 2022 examined patients who underwent SPT placement by urology or IR. Patients without 90‐day follow‐up were excluded. Patient demographics, indications for SPT placement, and perioperative, 30‐ and 90‐day postoperative complications were recorded using the Clavien‐Dindo (CD) classification system. Outcomes were compared between urology and IR. Multivariable logistic regression assessed associations between preoperative factors, specialty and major complications. Results: A total of 266 patients were included (179 urology, 87 IR). Median age was 68 years; 64% were male, and 56% had neurogenic bladder. Median catheter size was 18 Fr and 20 Fr for urology and IR, respectively ( p = 0.05). Perioperative complication rates were low and comparable (5.6% urology vs. 5.8% IR, p = 0.80). Most 30‐ and 90‐day complications were minor (CD grades 1–2), primarily urinary tract infections and SPT malfunction, while major complications (CD grades 3–5) were uncommon. Overall, 90‐day complication rates were similar (48% urology vs. 45% IR, p = 0.66), though major complications occurred more frequently in the IR group (11% vs. 5.2%, p = 0.04). On multivariable analysis, specialty, history of pelvic radiation, and prior pelvic surgery were not significantly associated with severe complications. Conclusion: Urology and IR have comparable, low complication rates for SPT placement. Perioperative complications are infrequent and more severe. Longer‐term complications were common but more likely to be minor, primarily urinary tract infections or SPT dislodgement with higher rates of urinary tract infections in SPTs placed by IR.
- 10 August 2026
- Published by Wiley in Neurourology and Urodynamics
Retrospective Evaluation of Contemporary Complication Rates and Severity After Suprapubic Tube Placement by Urology and Interventional Radiology
Introduction: To compare complication rates and severity associated with suprapubic tube (SPT) placement by urology versus interventional radiology (IR) and to identify patient factors associated with increased complication risk. Methods: A retrospective, single‐center review from 2017 to 2022 examined patients who underwent SPT placement by urology or IR. Patients without 90‐day follow‐up were excluded. Patient demographics, indications for SPT placement, and perioperative, 30‐ and 90‐day postoperative complications were recorded using the Clavien‐Dindo (CD) classification system. Outcomes were compared between urology and IR. Multivariable logistic regression assessed associations between preoperative factors, specialty and major complications. Results: A total of 266 patients were included (179 urology, 87 IR). Median age was 68 years; 64% were male, and 56% had neurogenic bladder. Median catheter size was 18 Fr and 20 Fr for urology and IR, respectively ( p = 0.05). Perioperative complication rates were low and comparable (5.6% urology vs. 5.8% IR, p = 0.80). Most 30‐ and 90‐day complications were minor (CD grades 1–2), primarily urinary tract infections and SPT malfunction, while major complications (CD grades 3–5) were uncommon. Overall, 90‐day complication rates were similar (48% urology vs. 45% IR, p = 0.66), though major complications occurred more frequently in the IR group (11% vs. 5.2%, p = 0.04). On multivariable analysis, specialty, history of pelvic radiation, and prior pelvic surgery were not significantly associated with severe complications. Conclusion: Urology and IR have comparable, low complication rates for SPT placement. Perioperative complications are infrequent and more severe. Longer‐term complications were common but more likely to be minor, primarily urinary tract infections or SPT dislodgement with higher rates of urinary tract infections in SPTs placed by IR.